Combined Spinal-epidural Versus Spinal Analgesia for Elective Caesarean Section in the Postoperative Period

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02273011

Enrollment

Registered

2014-10-23

Start date

2007-03-31

Completion date

2010-05-31

Last updated

2014-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Satisfaction

Brief summary

Combined spinal epidural (CSEA) and single shot spinal anesthesia (SSSA) are both well-established anesthetic methods for caesarean section. CSEA combines the advantages of spinal anesthesia for the surgery, and epidural anesthesia for postoperative pain management. The aim of this randomized trial was to compare analgesia and patient satisfaction with CSEA continuous epidural administration of local anesthetics versus SSSA with oral pain medication in the postoperative period.

Detailed description

Combined spinal epidural (CSEA) and single shot spinal anesthesia (SSSA) are both well-established anesthetic methods for caesarean section. CSEA combines the advantages of spinal anesthesia for the surgery, and epidural anesthesia for postoperative pain management. However, it is more time-consuming, and adds potentially risks of both single techniques. The aim of this randomized trial was to compare analgesia and patient satisfaction with CSEA continuous epidural administration of local anesthetics versus SSSA with oral pain medication in the postoperative period.

Interventions

PROCEDUREcaesarean section

elective caesarean section under regional anesthesia

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* American Society of Anesthesiologists-physical status: I or II * elective caesarean section

Exclusion criteria

* age under eighteen * maternal systemic diseases * allergies against the drugs used * systemic infection or local infection in the puncture area * dysfunctional coagulation * coagulation-inhibiting drugs

Design outcomes

Primary

Measure	Time frame	Description
patient's satisfaction	perioperative	Standardised questionnaire assessing pain, discomfort, anxiety

Secondary

Measure	Time frame	Description
additional oral pain medication	perioperative	Assessment of additionally requested oral pain medication
pain score	perioperative	Standardised questionnaire assessing pain by using the visual analogue scale

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026